Form 4: Arcus Biosciences CEO Terry J. Rosen Buys $201,561 Worth of Company Stock
SEC Form 4 Filing
Arcus Biosciences CEO Terry J. Rosen purchased 19,800 shares of RCUS stock at an average price of $10.175 per share on February 27, 2025.
Summary
- On February 27, 2025, Terry J. Rosen, the CEO of Arcus Biosciences, Inc. (RCUS), acquired 19,800 shares of common stock.
- The shares were purchased at a weighted average price of $10.175, with individual transactions ranging from $10.13 to $10.185.
- Following the transaction, Rosen directly owns 2,554,160 shares of Arcus Biosciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's stock purchase suggests confidence, but it's a single transaction and doesn't guarantee future performance.
Positives
- The CEO's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often monitored by investors as an indicator of management's sentiment regarding the company's valuation and future performance. It can be a positive signal, but should be considered alongside other factors.
Stakeholder Impact
- The stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of stock purchase transaction by Terry J. Rosen |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.